PMID- 38404520
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240227
IS  - 2772-3682 (Electronic)
IS  - 2772-3682 (Linking)
VI  - 23
DP  - 2024 Apr
TI  - Hypertension treatment cascade among men and women of reproductive age group in 
      India: analysis of National Family Health Survey-5 (2019-2021).
PG  - 100271
LID - 10.1016/j.lansea.2023.100271 [doi]
LID - 100271
AB  - BACKGROUND: Only a proportion of adults with hypertension are diagnosed and 
      receive recommended prescriptions despite the availability of inexpensive and 
      efficacious treatment. We aimed to estimate the prevalence of different stages of 
      hypertension treatment cascade among the reproductive age groups in India at the 
      national and state levels. We also identified the predictors of different stages 
      of the hypertension treatment cascade. METHODS: We used the nationally 
      representative data from National Family Health Survey (NFHS)-5. We included all 
      the males (15-54 years) and females aged 15-49. Socio-demographic factors, 
      anthropometric measurements, habits, comorbid conditions, and healthcare access 
      stratified the stages of the hypertension treatment cascade among hypertensives. 
      We used multinomial logistic regression to identify the determinants of the 
      treatment cascade levels. FINDINGS: We had data from 1,267,786 individuals. The 
      national prevalence of hypertension was 18.3% (95% CI: 18.1%-18.4%). Men (21.6%, 
      95% CI: 21.5%-21.7%) were found to have a higher prevalence as compared to women 
      (14.8%, 95% CI: 14.7%-14.9%). Among hypertensive individuals, 70.5% (95% CI: 
      70.3%-70.7%) had ever received a BP measurement ("screened"), 34.3% (95% CI: 
      34.1%-34.5%) had been diagnosed prior to the survey ("aware"), 13.7% (95% CI: 
      13.5%-13.8%) reported taking a prescribed anti-hypertensive drug ("under 
      treatment"), and 7.8% (95% CI: 7.7%-7.9%) had their BP under control 
      ("controlled"). Males, illiterates, poor, never married, residents of rural 
      areas, smokers/tobacco users, and alcoholic users were less likely to be in any 
      of the treatment cascades. INTERPRETATION: The prevalence of hypertension in 
      India is high. The "Rule of half" of hypertension does not apply to India as the 
      proportion of people screened, aware of their hypertension status, treated, and 
      controlled are lower than 50% at each stage. Program managers must improve access 
      to hypertension diagnosis and treatment, especially among men in rural areas and 
      populations with lower household wealth. FUNDING: None.
CI  - (c) 2023 The Authors.
FAU - Rao Guthi, Visweswara
AU  - Rao Guthi V
AD  - Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, 
      Tirupati, Andhra Pradesh, India.
FAU - Sujith Kumar, D S
AU  - Sujith Kumar DS
AD  - Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, 
      Tirupati, Andhra Pradesh, India.
FAU - Kumar, Sanjeev
AU  - Kumar S
AD  - Department of Community and Family Medicine, AIIMS, Bhopal, India.
FAU - Kondagunta, Nagaraj
AU  - Kondagunta N
AD  - Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, 
      Tirupati, Andhra Pradesh, India.
FAU - Raj, Sonika
AU  - Raj S
AD  - Public Health Masters Program, School of Medicine, University of Limerick, 
      Ireland.
FAU - Goel, Sonu
AU  - Goel S
AD  - Public Health Masters Program, School of Medicine, University of Limerick, 
      Ireland.
FAU - Ojah, Pratyashee
AU  - Ojah P
AD  - Biostatistics and Demography, International Institute for Population Sciences, 
      Mumbai, India.
LA  - eng
PT  - Journal Article
DEP - 20230922
PL  - England
TA  - Lancet Reg Health Southeast Asia
JT  - The Lancet regional health. Southeast Asia
JID - 9918419282806676
PMC - PMC10884964
OTO - NOTNLM
OT  - Hypertension
OT  - Large survey
OT  - Rule of half
OT  - Screening
OT  - Secondary data
COIS- None declared.
EDAT- 2024/02/26 06:43
MHDA- 2024/02/26 06:44
PMCR- 2023/09/22
CRDT- 2024/02/26 04:27
PHST- 2023/01/16 00:00 [received]
PHST- 2023/05/12 00:00 [revised]
PHST- 2023/08/18 00:00 [accepted]
PHST- 2024/02/26 06:44 [medline]
PHST- 2024/02/26 06:43 [pubmed]
PHST- 2024/02/26 04:27 [entrez]
PHST- 2023/09/22 00:00 [pmc-release]
AID - S2772-3682(23)00131-2 [pii]
AID - 100271 [pii]
AID - 10.1016/j.lansea.2023.100271 [doi]
PST - epublish
SO  - Lancet Reg Health Southeast Asia. 2023 Sep 22;23:100271. doi: 
      10.1016/j.lansea.2023.100271. eCollection 2024 Apr.